Greenleaf Trust Cuts Position in Humana Inc. (NYSE:HUM)

Greenleaf Trust cut its stake in Humana Inc. (NYSE:HUM) by 19.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,948 shares of the insurance provider’s stock after selling 712 shares during the period. Greenleaf Trust’s holdings in Humana were worth $934,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. grew its position in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Atwood & Palmer Inc. purchased a new stake in Humana during the third quarter valued at about $29,000. Hantz Financial Services Inc. purchased a new stake in Humana during the second quarter valued at about $35,000. Family Firm Inc. purchased a new stake in Humana during the second quarter valued at about $37,000. Finally, Hollencrest Capital Management purchased a new stake in Humana during the second quarter valued at about $40,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of NYSE HUM opened at $258.41 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The company has a 50 day simple moving average of $310.28 and a two-hundred day simple moving average of $337.43. The company has a market capitalization of $31.14 billion, a price-to-earnings ratio of 16.09, a P/E/G ratio of 1.91 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter last year, the firm earned $8.94 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. Analysts expect that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.37%. Humana’s payout ratio is 22.04%.

Analyst Ratings Changes

Several analysts have issued reports on HUM shares. Royal Bank of Canada cut their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and cut their price target for the company from $519.00 to $253.00 in a research report on Monday, October 7th. Oppenheimer cut their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target for the company in a research report on Tuesday, October 8th. Finally, TD Cowen downgraded shares of Humana from a “buy” rating to a “hold” rating and lowered their price objective for the company from $402.00 to $261.00 in a research note on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $315.33.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.